Company: CMND
Filing Date: 2025-11-17
Form Type: 424B5
Source: 0001213900-25-111233
Chunk: 22

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-17
Form: 424B5
Chunk 22
---

in our securities being delisted from Nasdaq. A delisting could substantially decrease trading in the Common Shares, adversely affect
the market liquidity of the Common Shares as a result of the loss of market efficiencies associated with Nasdaq and the loss of federal
preemption of state securities laws, adversely affect our ability to obtain financing on acceptable terms, if at all, and may result in
the potential loss of confidence by investors, suppliers, customers and employees and fewer business development opportunities. Additionally,
the market price of the Common Shares may decline further and shareholders may lose some or all of their investment.

<div align='center'>S-9

FORWARD-LOOKING STATEMENTS</div>

Some of the statements made
under “Prospectus Summary,” “Risk Factors,” “Use of Proceeds,” and elsewhere incorporated by reference
in this prospectus constitute forward-looking statements. In some cases, you can identify forward-looking statements by terminology such
as “may,” “will,” “should,” “expects,” “plans,” “project,” “anticipates,”
“believes,” “estimates,” “predicts,” “potential,” “intends,” or “continue,”
or the negative of these terms or other comparable terminology.

These forward-looking statements
may include, but are not limited to, statements relating to our objectives, plans, and strategies; statements that contain projections
of results of operations or of financial condition; expected capital needs and expenses; statements relating to the research, development,
completion and use of our products; and all statements (other than statements of historical facts) that address activities, events, or
developments that we intend, expect, project, believe, or anticipate will or may occur in the future.

Forward-looking statements
are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements
on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current
conditions, expected future developments, and other factors they believe to be appropriate.

Important factors that could
cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors
could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements,
including, but not limited to, the factors summarized below:

| ● | the ability of our pre-clinical and any future clinical trials to demonstrate safety and efficacy of our future product candidates, and other positive results; |

| ●